Negative Pressure Wound Therapy Market To Grow At 6.65% CAGR Till 2034
The global negative pressure wound therapy market size was exhibited at USD 2.85 billion in 2024 and is projected to hit around USD 5.43 billion by 2034, growing at a CAGR of 6.65% during the forecast period of 2024 to 2034.
Negative Pressure Wound Therapy Market Key Takeaways:
?????????????? ?????? ???????? ???????????? ????????????: https://www.novaoneadvisor.com/report/sample/7422
Increasing demand for advanced wound care is expected to propel negative pressure wound therapy (npwt) devices market. Single-use NPWT devices are gaining traction in the field of wound care management over conventional products. For instance, in January 2023, Smith+Nephew announced that the FDA cleared its Single Use Negative Pressure Wound Therapy (sNPWT) Systems PICO 7 and PICO 14 for new indications in closed surgical incisions, which can help lower the occurrence of dehiscence, postoperative seroma, and superficial and deep incisional Surgical Site Infections (SSIs).
The increasing prevalence of chronic diseases, such as diabetes, cancer, and autoimmune conditions, is further anticipated to propel the market over the forecast period. This is primarily attributable to the fact that diabetes often results in complications such as diabetic foot ulcers. As per a report by WHO, in March 2023, about 422 million live with diabetes globally in 2023, Diabetes can contribute to an increased occurrence and complexity of various wounds, including infections, ulcerations (such as leg or foot ulcers), and acute wounds like surgical and traumatic wounds.
In addition, the increasing prevalence of obesity is another key factor likely to drive market growth, as it is associated with lower extremity amputations and chronic wounds. According to the World Obesity Federation, estimated that around 1 billion people globally, including 1 in 7 men and 1 in 5 women, will be living with obesity by 2033. Obese people are at a higher risk of pressure ulcers, with lowered vascular action in adipose tissue. Thus, this factor will likely boost the demand for these products, leading to market growth.
Elderly people have low immunity levels and thus, are prone to chronic disorders, such as diabetes, cancers, and heart diseases. Rising geriatric population is a significant factor propelling the growth of the negative pressure wound therapy devices market. According to the WHO data published in October 2023, by 2033, one out of every six people worldwide will be 60 years or older. During this period, the number of individuals in this age group will rise from 1 billion in 2020 to 1.4 billion. By 2050, the global population of those aged 60 and above is anticipated to double, reaching 2.1 billion. Moreover, the number of people aged 80 years or older is projected to triple by 2050, reaching a total of 426 million, compared to the figures recorded in 2020. These abovementioned factors are expected to drive the demand for negative pressure wound therapy devices over the forecast period.
Market Concentration & Characteristics
The market growth stage is moderate, and the pace of the market growth is accelerating. The negative pressure wound therapy market is characterized by a moderate-to-high degree of growth. Key drivers include the global aging population, prevalence of chronic diseases, and advancements in NPWT devices. Regulatory compliance, reimbursement policies, and trend towards home healthcare also shape the market dynamics.
Key strategies implemented by players in negative pressure wound therapy market are new product launches, expansion, acquisitions, partnerships, and other strategies. In April 2023, Convatec Group PLC acquired 30 Technology Limited’s anti-infective nitric oxide technology platform, which includes new product assets and R&D. In addition to enhanced wound care, Convatec plans to explore the technical platform for use in other businesses.
The market is witnessing a substantial degree of innovation driven by rapid technological advancements and the increasing adoption of advanced products, particularly in home care settings. Companies investing significantly in these advanced technologies are gaining a competitive edge, contributing to the overall market growth. Thesingle-use systems, wireless remote monitoring, and enhanced patient mobility, the latest NPWT devices are designed to provide more effective and efficient wound healing solutions. Such advancements and innovations in negative pressure wound therapy drive market growth.
The market is significantly influenced by stringent quality protocols and regulatory norms enforced by various nations, aimed at ensuring patient safety and data integrity. Market participants with robust compliance measures and a proven track record of meeting regulatory standards not only enhance patient trust but also gain preference from MedTech sponsors.
Companies are actively acquiring development-stage firms to broaden their product portfolios, catering to a larger patient base. These collaborative efforts aim to strengthen relationships and improve the implementation of clinical programs pitched towards reducing hospitalizations for members. For instance, in March 2023, Convatec Group PLC completed the acquisition of Triad Life Sciences, Inc. to enter the wound biologics segment. Triad’s team, current portfolio, and product pipeline were transitioned to Convatec’s Advanced Wound Care (AWC) business, known as Convatec Advanced Tissue Technologies.
The market comprises a large number of medical device manufacturers leads to a highly fragmented market scenario.
Negative pressure wound therapy companies are increasingly prioritizing regional expansion to gain a competitive edge and expand their market reach. This involves forming partnerships, making acquisitions, and adopting localized marketing strategies to establish a stronger presence in key geographical areas. By customizing their products and services to cater to the unique healthcare requirements of different regions, these companies aim to improve accessibility and responsiveness, which in turn can lead to better market penetration. Overall, regional expansion is a crucial element for industry leaders to explore new markets, address specific healthcare demands, and drive sustained growth.?
Negative Pressure Wound Therapy Market Segments Insights:
Negative Pressure Wound Therapy Market By Product Insights
On the basis of product, the market has been segmented into conventional NPWT devices, single-use NPWT devices, and NPWT accessories. The conventional segment accounted for the largest market share of 85.0% in 2024. This can be attributed to their high price and increasing adoption globally. Conventional NPWT devices reduce the length of hospital stay for patients, reducing the total cost of treatment and favoring the adoption of this device over single use. Furthermore, it can be rented and purchased, which is expected to increase the usage rate of conventional NPWT in developing countries owing to its low purchasing power, thereby driving segment growth.
Negative Pressure Wound Therapy Market By Wound Type Insights
The chronic wounds segment dominated the market in 2024. This can be attributed to an increasing number of geriatric populations and an increase in the prevalence of chronic wounds, such as diabetic foot ulcers and venous pressure ulcers, are expected to drive segment growth. As per data published by Wound Care Advantage, in May 2024, about 8.2 million people over the age of 65 and above have chronic wounds in America. Thus, increasing geriatric population with chronic wounds is anticipated to drive segment growth during the forecast period.
Negative Pressure Wound Therapy Market By End-use Insights
Hospitals segment dominated the market in 2024 on account of a high volume of patients due to the increasing chronic diseases globally. In addition, NPWT devices are widely used in hospital settings, which include acute care centers and community hospitals. Moreover, the rising number of hospitals is anticipated the segment growth. According to the American Hospital Association, in 2023, around 6,129 hospitals were available in the U.S. Thus, introducing new healthcare hospitals and new patients for wound treatment spurs the demand for negative pressure wound therapy devices in the forecast period.
The home healthcare segment is expected to witness the fastest growth over the forecast period. NPWT therapy designed for home use is emerging, owing to the introduction of technologically advanced single-use and traditional NPWT systems. These innovations eliminate the necessity for hospitalization, making the overall therapy cost-efficient when applied in a home setting.
Negative Pressure Wound Therapy Market By Regional Insights
North America accounted for the highest market share in 2024. This can be attributed to the rising number of road accidents, sports injuries, and the presence of several key players in the region is anticipated to drive the market in North America. The region is continuously developing cost-efficient and advanced devices for the patients to capture a huge share of the market. In addition, the rise in the number of hospitals and the growing geriatric population are factors responsible for the regional market growth.
U.S. accounts for the largest market share in North America market. This can be attributed to the high incidence rate of chronic wounds in the U.S. and the rising geriatric population in U.S. is expected to boost the market growth. For instance, in May 2023, the CDC estimates that 6 in 10 adults in the U.S. currently live with a chronic disease such as cancer, heart disease, or diabetes.
Asia Pacific is expected to be the fastest-growing region during the forecast period because of the rising target population base with increasing chronic diseases, the need for medical equipment by the patients, and supportive government initiatives. In addition, the rapidly growing medical tourism industry in these countries can also be attributed to the increase in demand for NPWT in this region coupled with improvements in healthcare infrastructure will contribute to the region’s growth.
China accounts for the largest market share in Asia Pacific market. As per the National Library of Medicine report, the proportion of elderly people in China's population is increasing, indicating a demographic shift towards an aging society. As a result, the incidences of diabetes and diabetic foot have been increasing. These factors are expected to drive the segment’s growth over the forecast period.
Negative Pressure Wound Therapy Market Recent Developments
Some of the prominent players in the Negative pressure wound therapy market include:
Segments Covered in the Report
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2034. For this study, Nova one advisor, Inc. has segmented the global negative pressure wound therapy market.
By Product
By Wound Type
By End-use
By Region
领英推荐
Immediate Delivery Available | Buy This Premium Research https://www.novaoneadvisor.com/report/checkout/7422
Access our Premium Real Time Data Intelligence Tool, Visit: www.precedencestatistics.com
You can place an order or ask any questions, please feel free to [email protected]| +1 9197 992 333
About US
Nova One Advisor is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Nova One Advisor has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings.
Connect with Us
Address: Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
IND Address: 707, Nandan Probiz, Baner,?Pune (MH) – 411045, India
USA:?+1 804 441 9344
APAC:?+61 485 981 310 or +91 87933 22019
Europe:?+44 7383 092 044
Email: [email protected]
You can place an order or ask any questions, please feel free to contact at?[email protected] ?| +1 804 441 9344
Nova One Advisor Group Offer Other Reports:
Cell Therapy Market Size and Forecast:?The global?cell therapy market size was exhibited at USD 4.85 billion in 2023 and is projected to hit around USD 37.42 billion by 2033, growing at a CAGR of 22.67% during the forecast period 2024 to 2033.
Gene Therapy Market Size and Forecast?:?The global?gene therapy market size was exhibited at USD 8.75 billion in 2023 and is projected to hit around USD 52.40 billion by 2033, growing at a CAGR of 19.6% during the forecast period 2024 to 2033.
Cell And Gene Therapy Manufacturing Market Size and Forecast:?The global?cell and gene therapy manufacturing market size was estimated at USD 9.95 billion in 2023 and is projected to hit around USD 106.03 billion by 2033, growing at a CAGR of 26.7% during the forecast period from 2024 to 2033.
Cell and Gene Therapy Market?Size and Forecast:?The global?cell and gene therapy market size was estimated at USD 18.13 billion in 2023 and is projected to hit around USD 97.33 billion by 2033, growing at a CAGR of 18.3% during the forecast period from 2024 to 2033.
U.S. Cell Therapy Market Size and Forecast:?The?U.S. cell therapy market size was estimated at USD 2.88 billion in 2023 and is projected to hit around USD 19.67 billion by 2033, growing at a CAGR of 21.18% during the forecast period from 2024 to 2033.
U.S. Gene Therapy Market Size and Forecast:?The?U.S. gene therapy market size?was estimated at USD 3.19 billion in 2023 and is projected to hit around USD 18.50 billion by 2033, growing at a CAGR of 19.22% during the forecast period from 2024 to 2033.
T-cell Therapy Market Size and Forecast:?The global?T-Cell therapy market size?was exhibited at USD 3.85 billion in 2023 and is projected to hit around USD 79.62 billion by 2033, growing at a CAGR of 35.38% during the forecast period 2024 to 2033.
Cancer Immunotherapy Market?Size and Forecast:?The global?cancer immunotherapy market?size was valued at USD 126.19 billion in 2023 and is projected to surpass around USD 296.01 billion by 2033, registering a CAGR of 8.9% over the forecast period of 2024 to 2033.
Immunotherapy Drugs Market?:?The global?immunotherapy drugs market size was valued at USD 240.19 billion in 2023 and is projected to surpass around USD 1,300.38 billion by 2033, registering a CAGR of 18.4% over the forecast period of 2024 to 2033.
Clinical Trials Market Size and Forecast:?The?global clinical trials market size was estimated at USD 81.90 billion in 2023 and is projected to hit around USD 153.59 billion by 2033, growing at a CAGR of 6.49% during the forecast period from 2024 to 2033.
Biologics Market Size and Forecast: The?global biologics market size was estimated at USD 511.04 billion in 2023 and is projected to hit around USD 1,374.51 billion by 2033, growing at a CAGR of 10.4% during the forecast period from 2024 to 2033.
Biotechnology Market Size and Forecast:? The?global biotechnology market size was estimated at USD 1.54 Trillion in 2023 and is projected to hit around USD 5.68 Trillion by 2033, growing at a CAGR of 13.95% during the forecast period from 2024 to 2033.
Oncology? Market Size and Forecast: The?global oncology market size was estimated at USD 222.36 billion in 2023 and is projected to hit around USD 521.60 billion by 2033, growing at a CAGR of 8.9% during the forecast period from 2024 to 2033.
Cell And Gene Therapy Clinical Trials?Market Size and Forecast: The global cell and gene therapy clinical trials market size reached USD 11.62 billion in 2023 and is projected to hit around USD 47.40 billion by 2033, expanding at a CAGR of 15.09% during the forecast period from 2024 to 2033.
U.S. Clinical Trials Market Size and Forecast:?The?U.S. clinical trials market size was valued at USD 25.81 billion in 2023 and is projected to surpass around USD 41.57 billion by 2033, registering a CAGR of 4.88% over the forecast period of 2024 to 2033.
Active Pharmaceutical Ingredient CDMO Market:?The global active pharmaceutical ingredient CDMO market size was valued at USD 119.80 billion in 2023 and is anticipated to reach around USD 249.22 billion by 2033, growing at a CAGR of 7.6% from 2024 to 2033.
U.S. Pharmaceutical Market?:?The U.S. pharmaceutical market size was valued at USD 602.19 billion in 2023 and is projected to surpass around USD 1,093.79 billion by 2033, registering a CAGR of 6.15% over the forecast period of 2024 to 2033.
Viral Vector And Plasmid DNA Manufacturing Market:?The global viral vector and plasmid DNA manufacturing market size?was valued at USD 6.19 billion in 2023 and is anticipated to reach around USD 39.30 billion by 2033, growing at a CAGR of 20.3% from 2024 to 2033.
U.S. Viral Vector And Plasmid DNA Manufacturing Market ;?The U.S. viral vector and plasmid DNA manufacturing market size was valued at USD 2.45 billion in 2023 and is expected to be worth around USD 15.30 billion by 2033, with a registered CAGR of 20.1% during forecast period 2024 to 2033.
Compounding Pharmacies Market :?The global compounding pharmacies market size?was valued at USD 16.19 billion in 2023 and is anticipated to reach around USD 30.97 billion by 2033, growing at a CAGR of 6.7% from 2024 to 2033.
U.S. Compounding Pharmacies Market?:?The U.S. compounding pharmacies market size?is projected to be worth around USD 10.76 billion by 2033 from USD 6.31 billion in 2024, at a CAGR of 6.1% from 2024 to 2033.
Antibiotics Market: The?global antibiotics market size?was valued at USD 51.19 billion in 2023 and is projected to surpass around USD 85.80 billion by 2033, registering a CAGR of 5.3% over the forecast period of 2024 to 2033.
Biologics Market :?The?global biologics market size was estimated at USD 511.04 billion in 2023 and is projected to hit around USD 1,374.51 billion by 2033, growing at a CAGR of 10.4% during the forecast period from 2024 to 2033.
Biotechnology Market:?The?global biotechnology market size was estimated at USD 1.54 Trillion in 2023 and is projected to hit around USD 5.68 Trillion by 2033, growing at a CAGR of 13.95% during the forecast period from 2024 to 2033.
Next Generation Sequencing Market?:?The?global next generation sequencing market size was estimated at USD 9.19 billion in 2023 and is projected to hit around USD 66.04 billion by 2033, growing at a CAGR of 21.8% during the forecast period from 2024 to 2033.
Genome Editing Market ;?The?global genome editing market size?was valued at USD 8.45 billion in 2023 and is anticipated to reach around USD 40.48 billion by 2033, growing at a CAGR of 16.96% from 2024 to 2033.
U.S. Genome Editing Market:?The?U.S. genome editing market size was estimated at USD 3.55 billion in 2023 and is projected to hit around USD 16.49 billion by 2033, growing at a CAGR of 16.6% during the forecast period from 2024 to 2033.
U.S. Gene Synthesis Market?:?The?U.S. Gene Synthesis market size was valued at USD 700.90 million in 2023 and is projected to surpass around USD 3,118.73 million by 2033, registering a CAGR of 16.1% over the forecast period of 2024 to 2033.
Biopharmaceutical Market :?The global?Biopharmaceutical market size accounted for USD 327.46 billion in 2022 and is estimated to achieve a market size of USD 1,101.77 billion by 2032 growing at a CAGR of 12.9% from 2023 to 2032.
Immunotherapy Drugs Market?:?The?global immunotherapy drugs market size was valued at USD 240.19 billion in 2023 and is projected to surpass around USD 1,300.38 billion by 2033, registering a CAGR of 18.4% over the forecast period of 2024 to 2033.
Cancer Immunotherapy Market:?The global cancer immunotherapy market size was valued at USD 126.19 billion in 2023 and is projected to surpass around USD 296.01 billion by 2033, registering a CAGR of 8.9% over the forecast period of 2024 to 2033.
U.S. Plasmid DNA Manufacturing Market?:?The U.S. plasmid DNA manufacturing market size?was valued at USD 711.90 million in 2023 and is projected to surpass around USD 4,885.15 million by 2033, registering a CAGR of 21.24% over the forecast period of 2024 to 2033.
U.S. Precision Medicine Market?:?The?U.S. precision medicine market size was valued at USD 24.95 billion in 2023 and is projected to reach around USD 76.12 billion by 2033, registering a CAGR of 11.80% from 2024 to 2033.